By analyzing the RNA-Seq data set from the Chinese Glioma Genome Altas (CGGA), we found that high HACE1 expression clearly reduced the survival in patients with WHO grade III and IV (Fig. 1c). This evidence concerns the gene HACE1 and central nervous system cancer.